Home/Filings/4/0001127602-23-026188
4//SEC Filing

Chopas James George 4

Accession 0001127602-23-026188

CIK 0001492422other

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 4:20 PM ET

Size

4.4 KB

Accession

0001127602-23-026188

Insider Transaction Report

Form 4
Period: 2023-10-23
Chopas James George
VP/Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2023-10-23$46.04/sh132$6,07732,680 total
Footnotes (1)
  • [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001836430

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:20 PM ET
Size
4.4 KB